Pulse Biosciences price to book ratio PLSE
Market value divided by the book value of the company's net assets, since 2016.
- Today, Nov 2, 2026
- 37.9×
- 10-year median
- 9.7×
- Against its 10-year history
- 97th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 2.0× to 48.8×
- Peer median
- 4.9×
Pulse Biosciences' price to book ratio is 37.9× as of Nov 2, 2026.
That is above its ten-year median of 9.7×, higher than on 97% of days in the last ten years.
Over that time it ranged from 2.0× in May 2022 to 48.8× in Aug 2024.
The median for 10 medical instruments and supplies stocks of a similar size is 4.9×.
Price to book ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 37.9× | 9.8× | 38.6× |
| 2025 | 10.5× | 8.4× | 16.9× |
| 2024 | 14.0× | 8.5× | 48.8× |
| 2023 | 12.9× | 3.7× | 23.3× |
| 2022 | 16.7× | 2.0× | 17.4× |
| 2021 | 9.3× | 9.3× | 34.2× |
| 2020 | 18.5× | 2.9× | 18.5× |
| 2019 | 6.9× | 3.9× | 11.7× |
| 2018 | 6.9× | 4.7× | 8.4× |
| 2017 | 7.7× | 3.0× | 18.1× |
| 2016 | 3.1× | 2.0× | 5.1× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Pulse Biosciences' size, closest first, today.
| Company | Price to book ratio |
|---|---|
| PLSEPulse Biosciences | 37.9× |
| NVSTEnvista | 1.3× |
| ICUIICU Medical | 1.9× |
| BMIBadger Meter | 6.9× |
| ATRCAtriCure | 5.9× |
| WRBYWarby Parker | 7.5× |
| VNTVontier | 4.2× |
| MMSIMerit Medical Systems | 2.9× |
| HAEHaemonetics | 6.5× |
| UFPTUFP Technologies | 4.8× |
| MSAMSA Safety | 5.1× |
| Peer median | 4.9× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on Pulse Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.